Water

Water

SCHEMBL2820889

CCOC(CN)(OCC)OCC.O

nearest known ligand 0.30

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL149016 0.97 CYP2D6 (0.32) CYP2D6
Fluoride SCHEMBL4617191 0.94 CYP2D6 (0.30) CYP2D6
Hydrochloric Acid SCHEMBL5153044 0.94 CYP2D6 (0.30) CYP2D6
Bromide SCHEMBL2351772 0.94 CYP2D6 (0.30) CYP2D6
SCHEMBL6900156 0.82
Oxalic Acid SCHEMBL1052749 0.82 ALOX15 (0.33)
SCHEMBL7629773 0.80 ADRB2 (0.39)
SCHEMBL6326338 0.78
Nitric Acid SCHEMBL8210908 0.78 CA5A (0.35)
SCHEMBL9096601 0.73 CA1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944853-B2 Color inhibitor for quaternary ammonium hydroxide in non-aqueous solvent SACHEM, INC. (US) 2018-04-17 US disclosed
EP-2943465-B1 COLOR INHIBITOR FOR QUATERNARY AMMONIUM HYDROXIDE IN NON-AQUEOUS SOLVENT SACHEM INC (US) 2017-03-15 EP disclosed
US-20150353824-A1 COLOR INHIBITOR FOR QUATERNARY AMMONIUM HYDROXIDE IN NON-AQUEOUS SOLVENT SACHEM, INC. 2015-12-10 US disclosed
EP-2943465-A1 COLOR INHIBITOR FOR QUATERNARY AMMONIUM HYDROXIDE IN NON-AQUEOUS SOLVENT Sachem, Inc. (US) 2015-11-18 EP disclosed
WO-2014110308-A1 COLOR INHIBITOR FOR QUATERNARY AMMONIUM HYDROXIDE IN NON-AQUEOUS SOLVENT SACHEM, INC. (US) 2014-07-17 WO disclosed
EP-1919853-B1 REMOVAL OF METAL IONS FROM ONIUM HYDROXIDES AND ONIUM SALT SOLUTIONS SACHEM INC (US) 2010-10-27 EP disclosed
EP-1472188-B1 PURIFICATION OF ONIUM HYDROXIDES BY ELECTRODIALYSIS SACHEM INC (US) 2010-10-06 EP disclosed
EP-1235752-B1 PROCESS FOR RECOVERING ORGANIC HYDROXIDES FROM WASTE SOLUTIONS SACHEM INC (US) 2010-07-28 EP disclosed
US-7572379-B2 Removal of metal ions from onium hydroxides and onium salt solutions SACHEM, INC. (US) 2009-08-11 US disclosed
EP-1919853-A2 REMOVAL OF METAL IONS FROM ONIUM HYDROXIDES AND ONIUM SALT SOLUTIONS Sachem, Inc. (US) 2008-05-14 EP disclosed
WO-1999036363-A1 PROCESS FOR RECOVERING ONIUM HYDROXIDES FROM SOLUTIONS CONTAINING ONIUM COMPOUNDS SACHEM, INC. (US) 1999-07-22 WO disclosed
US-5910237-A Process for recovering organic hydroxides from waste solutions SACHEM, INC. (US) 1999-06-08 US disclosed
US-5868916-A Process for recovering organic hydroxides from waste solutions SACHEM, INC. (US) 1999-02-09 US disclosed
WO-1998035748-A1 PROCESS FOR RECOVERING ORGANIC HYDROXIDES FROM WASTE SOLUTIONS SACHEM, INC. (US) 1998-08-20 WO disclosed
US-5753097-A Process for purifying hydroxide compounds SACHEM, INC. (US) 1998-05-19 US disclosed
EP-0834346-A2 Process for purifying hydroxide compounds Sachem, Inc. (US) 1998-04-08 EP disclosed
EP-0834345-A2 Electrochemical process for purifying hydroxide compounds Sachem, Inc. (US) 1998-04-08 EP disclosed
US-5709790-A Electrochemical process for purifying hydroxide compounds SACHEM, INC. (US) 1998-01-20 US disclosed
EP-0652041-A2 Method for producing high purity hydroxides and alkoxides Sachem, Inc. (US) 1995-05-10 EP disclosed
US-5389211-A Method for producing high purity hydroxides and alkoxides SACHEM, INC. (US) 1995-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353824-A1 COLOR INHIBITOR FOR QUATERNARY AMMONIUM HYDROXIDE IN NON-AQUEOUS SOLVENT IDH3A, IDH3B, DHX35 CYP2D6 2829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.